A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
Condition: Fabry's Disease Interventions: Drug: AGALSIDASE BETA (GZ419828); Drug: Acetaminophen; Drug: Diphenhydramine; Drug: Dexamethasone; Drug: Montelukast Sponsor: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials